|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09688 ZAI LAB
Nominal 
20.360 -0.380 (-1.832%) | 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Turnover | 398,988 | 49.591% | 266,719 | 215,040 | 144,312 | 48,958 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 5,300 | -24.351% | 7,006 | 3,113 | (10,201) | 29,076 | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | -- | -- | -- | |
| Profit / (Loss) before Taxation | (257,103) | -23.166% | (334,620) | (443,065) | (703,414) | (267,786) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | (221) | (1,057) | (1,119) | |
| Profit / (Loss) Attributable to Shareholders | (257,103) | -23.166% | (334,620) | (443,286) | (704,471) | (268,905) | |
| 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Net Finance Costs / (Income) | (19,714) | -20.976% | (24,947) | 41,821 | (6,851) | (4,939) |
| Depreciation & Amortisation | 12,556 | 39.063% | 9,029 | 8,227 | 6,487 | 4,640 |
| Directors' Emoluments | 18,068 | 7.190% | 16,856 | 14,610 | 13,337 | -- |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -26.000 | -25.714% | -35.000 | -46.000 | -76.000 | -34.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.217) | -- | (0.205) | (0.384) | (0.591) | (0.278) |
| NBV per share ($) | 0.768 | -- | 0.805 | 1.068 | 1.444 | 1.332 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -89,165 |
| %Change | -33.334% |
| EPS / (LPS) | USD -0.080 |
| NBV Per Share ($) | USD 0.713 |